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Abstract Along with known lymphokines involved in the
regulation of hematopoiesis, a new differentiating factor
(myelopeptide-4, MP-4) for myeloid cells was found. The peptide
(Phe-Arg-Pro-Arg-Ile-Met-Thr-Pro) originally isolated from the
culture medium of porcine bone marrow cell culture was
examined for its ability to induce differentiation in two human
myeloid leukemia cell lines, HL-60 and K-562. Agents with well-
known differentiation-inducing activity, such as phorbol myr-
istate acetate, dimethylsulfoxide and the lymphokines were used
as a reference. It has been shown that MP-4 significantly
influences the integral characteristics of metabolism, expression
of surface antigens and morphology of these cells. It decreased
the level of chromosomal DNA synthesis and, in parallel,
increased the total protein synthesis in both HL-60 and K-562
cells. MP-4 induced the expression of CD14 monocyte-specific
surface antigen and the appearance of mature monocytes/
macrophages in HL-60 cell cultures. There was a good
correlation of cell metabolic/morphological changes and the
CD14 marker expression for HL-60 cells. A similar phenomenon
was observed in K-562 cells treated with MP-4 when the levels of
hemoglobin synthesis were detected in their cytoplasm. Thus, we
consider MP-4 as a new endogenous differentiating factor for
myeloid cells.
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1. Introduction
An in vitro di¡erentiation of human myeloid cells is in-
duced by many factors [1^5] and many maturation inducers
(MIs; the cytokines) have been identi¢ed and cloned [6,7]. It is
known that most di¡erentiation-inducing factors for myeloid
cells are lymphokines with a short-term life (i.e. humoral me-
diators by nature), whereas the bone marrow is the main site
of di¡erentiation of the cells. Only limited information is
available on factors released from the bone marrow and on
regulating myeloid maturation in situ.
Earlier a group of bone marrow bioregulatory mediators
was revealed [8,9] ; they were called myelopeptides (MPs).
MPs have a wide spectrum of functional activities: immuno-
stimulating, immunoregulating and opiate-like [8^12]. Several
individual MPs (MP-1, MP-2, etc.) responsible for these ac-
tivities were originally isolated from the supernatant of por-
cine bone marrow cell culture medium and they were identi-
¢ed and synthesized [10^13]. The sequence of MP-4 is known
[13], but its function has not been established.
In the present study we tested the ability of MP-4, peptide
Phe-Arg-Pro-Arg-Ile-Met-Thr-Pro, to induce the di¡erentia-
tion of human myeloid HL-60 and K-562 leukemia cells and
compared it with that of known di¡erentiating agents (phor-
bol myristate acetate (PMA), dimethylsulfoxide (DMSO) and
the lymphokines). We show that MP-4 is able to induce the
maturation of both HL-60 and K-562 blast cells. The results
suggest that this endogenous factor may be important in the
control of di¡erentiation of normal and leukemic myeloid
cells and could be of therapeutic value for acute myeloid
leukemia and myelodysplastic disorders.
2. Materials and methods
2.1. MPs
MP-4 was synthesized in the Laboratory of Peptide Chemistry,
Cardiological Center, Moscow, Russia. The isolation and identi¢ca-
tion of MP-4 have already been described (see [13] for details).
2.2. Cell lines and cell cultures
HL-60 and K-562 cells are human myeloid leukemia cell lines, both
obtained from the Culture Collection of Institute of Cytology, St.
Petersburg, Russia. The cell lines were maintained in standard
RPMI 1640 medium supplemented with 10% heat-inactivated fetal
calf serum, 20 mM HEPES, 2 mM L-glutamine and 50 Wg/ml each
of gentamicin and tylosin (all reagents from Flow Laboratories, UK).
All cells were con¢rmed to be free from mycoplasmal contamination.
The morphology of HL-60 cells was assessed by Romanovsky^Giem-
sa staining.
2.3. Detection of chromosomal DNA and protein syntheses by
pulse-labeling of cells
The HL-60 and K-562 cells were cultured in standard medium in
24-well £at-bottom plates (Nunclon, Denmark) in the presence of
MP-4 or other agents for 3 days. The cells were then washed and
recultured for 3 days. Each culture was pulse-labeled with 2 WCi/ml
[3H]thymidine (19 Ci/mmol, LMO, Russia) together with 1 WCi/ml
[14C]glycine (50 mCi/mmol, LMO) for 4 h before termination of the
total culture time of 6 days. The trichloroacetic acid-insoluble precip-
itates containing DNA and the main portion of the cell protein (with-
out histones) were washed three times with 10% cold trichloroacetic
acid and 70% methanol. The content of 3H-DNA/14C-protein was
measured in the scintillation toluene mixture by using a special pro-
gram of counting the double radioactive label. The mean dpm in
triplicate cultures was analyzed.
2.4. Detection of CD14 surface marker by £ow cytometry
After preincubation with MP-4 or PMA (Serva, Germany) and the
following culturing, HL-60 cells were incubated with mouse monoclo-
nal antibodies against CD14 antigen (LM14; Sorbent Ltd., Russia) at
the standard dilution for 30 min on ice. Then, the cells were washed
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with phosphate-bu¡ered saline and incubated with FITC-conjugated
anti-mouse IgG (H+L) sheep IgG F(abP)2 (Sorbent Ltd.) at the stan-
dard dilution for 30 min on ice. After the ¢nal wash, the cells were
¢xed in 2% paraformaldehyde solution and analyzed by £ow cyto-
metry (EPICS-ELITE, Coulter, USA).
2.5. T-lymphocyte conditioned medium (CM) and lymphokines
Mononuclear cells from peripheral blood of healthy donors were
separated by Ficoll-Paque centrifugation and the T-lymphocytes were
puri¢ed and identi¢ed according to the described method [10]. T-lym-
phocytes (1U106 cells/ml) were cultured in standard medium with
3 Wg/ml of phytohemagglutinin (PHA, Flow Laboratories) and T-
lymphocyte CM was collected from 3-day cultures. This CM was
used as a source of di¡erentiation-inducing lymphokines for HL-60
cells. The MI activity present in the CM has been shown to be derived
from PHA-stimulated human T-lymphocytes [5,14].
3. Results
We examined the e¡ects of MP-4 on the chromosomal
DNA and protein syntheses in myeloid leukemia HL-60 cell
line, using a double [3H]thymidine/[14C]glycine label. The cells
were cultured with various concentrations of MP-4 for 3 days,
then washed, cultured again and pulse-labeled. Fig. 1 shows
that the level of the DNA synthesis decreased (to 15^40% of
the control values) with a simultaneous increase in the level of
the total protein synthesis (by 130^200%) in the presence of
MP-4. These changes are typical of a cell di¡erentiation pro-
cess [5,14^16]. The 3H-DNA/14C-protein ratio characterizes
the proportion of proliferation and di¡erentiation processes
in HL-60 cells in the presence of MP-4 (Fig. 1). The e¡ects of
MP-4 depended on its concentration in the culture medium:
an optimal concentration of MP-4 (1 Wg/ml) induced maximal
metabolic changes in the HL-60 cells according to minimal
changes in the 3H-DNA/14C-protein mean (Fig. 1).
Speci¢c morphological changes in the HL-60 cells treated
with MP-4 were evident on the eighth day of the total culture
time. Determination of morphology by Romanovsky^Giemsa
staining indicated the appearance of mature monocytes/mac-
rophages in the HL-60 cell cultures. Under the in£uence of
MP-4 (5^10 Wg/ml), the content of monocyte/macrophage-like
cells was about 30^40% of those in the original population of
HL-60 blasts and more than 50% of these cells matured at an
MP-4 concentration of 1 Wg/ml. A low degree (5%) of sponta-
neous monocyte maturation was observed. These results show
that myeloid HL-60 leukemia cells are sensitive to the peptide:
MP-4 signi¢cantly in£uences their metabolism, inducing dif-
ferentiation in the monocytic pathway.
Along with the antiproliferative e¡ects, we examined the
ability of MP-4 to induce the expression of CD14 surface
marker in a leukemia HL-60 cell line and compared it with
that of PMA. It is known that PMA induces di¡erentiation of
HL-60 cells into monocytes/macrophages [3,5]. The HL-60
cells were incubated in the presence of various concentrations
of MP-4 or PMA and then analyzed for CD14 expression by
£ow cytometry. As shown in Table 1, incubation with the
peptide resulted in CD14 monocyte antigen expression on
HL-60 cells according to the inhibition of their growth (Fig.
1). The maximal level of the CD14-positive cells (to 48% of
the control values) was at an MP-4 concentration of 1 Wg/ml,
as compared to that in the presence of PMA (72%). At the
same time, no HL-60 cells were stained by anti-CD3 antibod-
ies which recognize T-cell-speci¢c surface antigens. The mean
£uorescence intensity (density of surface CD14 antigen) was
also raised by MP-4 from 100 (control) to 120 at the peptide
Fig. 1. E¡ects of MP-4 on the chromosomal DNA and total protein
synthesis of HL-60 cells. On the Y-axis: to the left, the content of
3H-DNA and 14C-protein (%) and, to the right, the 3H-DNA
(dpm)/14C-protein (dpm) ratio. The cells were cultured in the pres-
ence of various concentrations of MP-4 for 3 days. After the sixth
cultivation day, the cells were pulse-labeled with [3H]thymidine/
[14C]glycine. Results were expressed as percent of control values
(without MP-4) of four representative experiments; average content
of 3H-DNA and 14C-protein in controls was 40 000 and 2800 dpm,
respectively.
Fig. 2. E¡ects of MP-4 on the chromosomal DNA and total protein
synthesis of K-562 cells. The culture conditions and pulse-labeling
of K-562 cells were as in Fig. 1. Results were expressed as percent
of control values of three representative experiments; average con-
tent of 3H-DNA and 14C-protein in controls was 76 000 and 10 000
dpm, respectively.
Table 1
E¡ects of MP-4 on CD14 antigen expression in HL-60 cells




None 5 þ 3 100
PMA (4 nM) 72 þ 8 166
MP-4 (Wg/ml)
0.01 39 þ 5 112
0.1 41 þ 5 115
1 48 þ 6 120
5 28 þ 4 106
50 14 þ 5 102
HL-60 cells were preincubated with MP-4 or PMA for 3 days.
Then, the cells were washed with RPMI 1640 medium. After 7 days
of total culture time, the cells were evaluated for CD14 expression
using monoclonal antibody LM14 followed by FITC-conjugated
anti-mouse IgG(H+L) sheep IgG F(abP)2 on £ow cytometry. Values
are the means þ S.D. of triplicate independent determinations.
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concentration of 1 Wg/ml (Table 1). The maximum of the
mean (166) was obtained in the presence of PMA.
Thus, a good correlation between metabolic changes and
CD14 monocyte antigen expression on HL-60 cells in the
presence of MP-4 was observed.
The action of MP-4 on chromosomal DNA and protein
syntheses was also examined in another myeloid leukemia
K-562 cell line and compared with that of DMSO (Serva).
It is known that erythroleukemia K-562 cells respond to low
concentrations of DMSO by a decrease in their growth and
initiation of hemoglobin synthesis [15]. As shown in Fig. 2,
the action of MP-4 on the growth of K-562 cells at a concen-
tration of 0.001 Wg/ml was more e¡ective than that of DMSO
(1.5%).
The growth of K-562 cells was also more sensitive to the
peptide as compared to that of HL-60 cells (Fig. 1): about
50% inhibition of the DNA synthesis was observed at low
(0.001^0.1 Wg/ml) concentrations of MP-4. In this way, at a
100-fold lower concentration, maximum changes in the
3H-DNA/14C-protein ratio took place (Fig. 2).
Examination of the e¡ect of DMSO on hemoglobin syn-
thesis in K-562 cells showed that the number of hemoglobin-
containing cells in the cultures begins to increase by 3^4 days
after 1 day preincubation in 1.5% DMSO. After 6 days of
total culture time, about 50% of the K-562 cells were stained
positively with the benzidine reagent (i.e. the cells were hemo-
globin-containing) if DMSO was added. At the same time
MP-4 added to K-562 cultures was also e¡ective in initiating
hemoglobin synthesis ; over 50% of the cells stained with ben-
zidine reagent at 0.001 Wg/ml of MP-4. There is a good corre-
lation between growth inhibition and hemoglobin synthesis in
K-562 cells under the action of MP-4.
Thus, the antiproliferative e¡ect of MP-4 is not only man-
ifested on the leukemia HL-60 cell line but myeloid leukemic
K-562 cells are also growth-inhibited and matured under the
in£uence of this peptide.
We compared the e¡ects of MP-4 and some MIs, such as
PMA or protein factors, on the di¡erentiation of myeloid
HL-60 cells. It is known that mitogen-stimulated human
blood T-lymphocytes can produce protein factors inducing
terminal di¡erentiation of HL-60 cells in the monocytic path-
way [5,14]. These factors, contained in the CM of PHA-stimu-
lated human T-lymphocytes, are called di¡erentiation-induc-
ing factors [5] or MI [14].
Using the T-lymphocyte CM as lymphokines (MI) and
PMA as a reference of the monocyte di¡erentiation, we exam-
ined the e¡ects of MP-4 on the chromosomal DNA synthesis
and on the morphology of HL-60 cells. As one can see from
Fig. 1 and Table 1, there is a good correlation between the
inhibition of DNA synthesis or the content of monocytes/
macrophages and the CD14 antigen expression in HL-60
cell line in the presence of MP-4. Fig. 3 illustrates once
more the ability of MP-4 to induce a high level of monocytic
di¡erentiation in the HL-60 cells as compared to other agents:
under the action of MP-4 the content of blasts falls and more
than 50% mature monocytes/macrophages appear. The MP-4
di¡erentiation e¡ects on HL-60 cells were almost similar to
those of MI (Fig. 3). At the same time another MP, MP-3
(Leu-Val-Cys-Tyr-Pro-Gln), does not change the integral met-
abolic and morphological characteristics of the HL-60 cells as
well as those of K-562 cells. Thus, the MP-4 e¡ects on these
cells are rather speci¢c. The results indicate that MP-4, like
lymphokines and PMA, can induce the terminal di¡erentia-
tion of human myeloid HL-60 leukemia cells in the monocytic
pathway.
4. Discussion
Many cytokine and non-cytokine factors are known to act
on normal and leukemic myeloid cell types, a¡ecting their
proliferation and di¡erentiation, as previously described [1^
7,14^18]. It is known that most endogenous MIs for human
myeloid cells, including gamma interferon and lymphotoxin
[1,5,17], are lymphokines and may be involved in the physio-
logical regulation of hematopoiesis. It is known that lympho-
kines (e.g. IL-3) being humoral factors have not been detected
in normal bone marrow which is the main site of maturation
of myeloid cells. However, only little information is available
on substances released in the bone marrow and on regulating
myeloid maturation in situ.
In this study, we obtained evidence for the existence of the
di¡erentiating factor (MP-4) for myeloid cells. The sequence
of MP-4 was known [13] but its function had not been exam-
ined. Our experiments indicate that MP-4 is able to induce the
maturation of both myeloid leukemia HL-60 and K-562 blast
cells by the inhibition of chromosomal DNA replication with
a simultaneous increase in the total protein synthesis. These
characteristics are typical for a cell di¡erentiation process
[5,14^18]. The dose dependence for MP-4 inhibitory e¡ects
in two leukemia cell lines show that K-652 cells are more
sensitive to the peptide than HL-60 cells. A good correlation
between metabolic/morphological changes and CD14 mono-
cyte antigen expression on the HL-60 cells or hemoglobin
synthesis in the K-562 cells in the presence of MP-4 is also
observed. At the same time other MPs do not in£uence the
cells, i.e. the MP-4 e¡ects on both HL-60 and K-562 myeloid
cells are rather speci¢c. The ability of MP-4 to induce the
di¡erentiation of leukemia HL-60 cells is comparable with
that of lymphokines inducing monocyte di¡erentiation in
these cells [5,14].
It is known that the antiproliferative e¡ects of most endog-
Fig. 3. Di¡erentiation of HL-60 cells in the presence of MP-4 and
known MIs. The cells were cultured for 3 days with MP-3 or MP-4
(1 Wg/ml each) or PMA (4 nM) or MI (a 10% T-lymphocyte CM
desired on the x-axis as MI). After 8 days of cultivation, the cells
were harvested and evaluated by the Romanovsky^Giemsa stain to
determine the monocyte/macrophage ratio. Results were expressed
as mean ( þ S.D.)% cells bearing the morphology (shown as % on
the y-axis) of three independent experiments.
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enous MIs are not exclusive for leukemic cells : normal hem-
atopoietic stem cells are inhibited as well [1,5,14,17,18]. Thus,
MP-4 may also be important in the control of proliferation
and maturation of normal myeloid cells.
Our results show that MP-4 is a new di¡erentiating factor
for myeloid cells. This peptide of bone marrow origin has a
low molecular weight and can be easily synthesized. These
¢ndings suggest the possibility of using MP-4 not only in
acute myeloid leukemias, but also in myelodysplastic disor-
ders, which are de¢ned by an impairment of myeloid cell mat-
uration, when di¡erentiation therapy is indicated.
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